Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 66 publications
Analysis of Galectin Binding to Blood Group Expressing Bacteria.
Journal: Methods in molecular biology (Clifton, N.J.)
Published: September 02, 2026
Defining the Specificity of Blood-Group-Binding Lectins Through Microarray Analysis.
Journal: Methods in molecular biology (Clifton, N.J.)
Published: September 02, 2026
Expression and Characterization of Blood Group Binding Lectins.
Journal: Methods in molecular biology (Clifton, N.J.)
Published: September 02, 2026
Endoscopic balloon dilatation of primary obstructive megaureter: An effective first line management in children.
Journal: Journal of pediatric urology
Published: May 29, 2024
Response to letter to the editor: are there anatomical limiting factors to foreskin reconstruction at the time of single-stage hypospadias repair?
Journal: Journal of pediatric urology
Published: February 25, 2024
Kelly's VV-plasty for catheterising channels; first reported case series.
Journal: Journal of pediatric urology
Published: February 04, 2024
Galectin-4 Antimicrobial Activity Primarily Occurs Through its C-Terminal Domain.
Journal: Molecular & cellular proteomics : MCP
Published: July 19, 2023
Inflammatory and neurodegenerative serum protein biomarkers increase sensitivity to detect disease activity in multiple sclerosis.
Journal: medRxiv : the preprint server for health sciences
Published: July 18, 2023
Inflammatory and neurodegenerative serum protein biomarkers increase sensitivity to detect clinical and radiographic disease activity in multiple sclerosis.
Journal: Nature communications
Published: June 16, 2023
Clinical validation of a multi-protein, serum-based assay for disease activity assessments in multiple sclerosis.
Journal: Clinical immunology (Orlando, Fla.)
Published: April 20, 2023
Are there anatomical limiting factors to foreskin reconstruction at the time of single-stage hypospadias repair?
Journal: Journal of pediatric urology
Published: March 10, 2023
Nasal administration of anti-CD3 mAb (Foralumab) downregulates NKG7 and increases TGFB1 and GIMAP7 expression in T cells in subjects with COVID-19.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: March 07, 2023
Last Updated: 09/26/2026